Sheba Medical Center: A Global Innovation Hub Rising from Conflict with Over $1 Billion Raised

In 1948, the cheers celebrating the establishment of the State of Israel had not yet faded when the entire nation was engulfed in the dark smoke of the Middle East War. That same year,Sheba Medical Center(Hereinafter referred to as “Sheba”) was established in a series of abandoned military barracks, tasked with the care of wounded soldiers. At its inception, the conditions for founding Sheba Hospital were far from favorable.

Amidst turbulent times, heroes emerge. Sheba has continuously accumulated developmental strength under a unique historical backdrop, ultimately rising from the ashes like a phoenix of medical innovation. Today, Sheba stands atop the “high ridge” of the medical community.

First, in terms of rankings, Sheba is not only the leading medical center in the Middle East but has also been rated by Newsweek as “Top 10 Best Hospitals in the World”，and ranked among the top for three consecutive years。

Secondly, in terms of scale, Sheba is the largest and most comprehensive medical center in Israel and even the entire Middle East region,A total of 150 departments and outpatient clinics, covering nearly all specialties, among which obstetrics, gynecology, pediatrics, neonatology, and rehabilitation enjoy high international reputations.

Finally, Sheba’s research prowess should not be underestimated. As one of Israel’s most important research centers, the hospital has achieved notable scientific milestones, including TIL immunotherapy for metastatic melanoma, the targeted drug olaparib for pancreatic cancer, the Phase III clinical trial of the world’s first “gene-breaking” therapy for hemophilia, and telemedicine projects for coronavirus.

The aforementioned aspects demonstrate that Sheba Medical Center stands head and shoulders above its peers in both clinical practice and scientific research. So, how has Sheba, despite its “inherent disadvantages,” risen from the ashes to become a phoenix of medical innovation?VBInsight conducted an in-depth analysis.

“The phoenix perches only on wutong trees, feeds only on bamboo seeds, and drinks only from sweet springs.” This medical phoenix is no exception! To strengthen its wings, Sheba Medical Center regards clinical practice as the wutong tree, scientific research as the bamboo seeds, and education as the sweet spring. By adhering to these standards, Sheba has taken the lead among modern medical centers.An Integrated Path of Comprehensive Development Combining Scientific Research, Clinical Practice, and Teaching Training.

It is worth noting that these three elements are closely interconnected, forming a complete and healthy ecosystem that firmly lays the foundation for the translation of medical innovations.

First, real-world cases serve as a fertile ground for scientific research.According to statistics, Sheba provides medical services to more than 1 million patients annually and conducts at least 25% of Israel’s medical research projects. It is this substantial volume of clinical cases that facilitates the hospital’s close integration of clinical treatment with medical research.

Second, the “satiating” effect of scientific research outcomes, namely, driving development through scientific innovation.In addition to participating in more than 5,000 innovative projects, Sheba Medical Center also develops new drugs, therapies, and technologies with the biotechnology and pharmaceutical industries through international cooperation.Johnson & Johnson, Roche, Pfizer, Merck & Co., NovartisWorld-leading medical technology companies and pharmaceutical enterprises, among others, maintain long-term, in-depth collaborations with Sheba.

At the same time, research projects also bring substantial revenue to hospitals. It is reported that in 2011, Sheba Medical Center topped the list among Israeli hospitals in terms of income generated from research, amounting to42.4 million new shekels (equivalent to RMB 84 million).

Finally, education and training are the source of talent innovation and the driving force behind overall medical innovation.In 2012, the then Deputy Director of Sheba HospitalDr. ZadesIt is believed that “talent is the source of innovation, and future competition will primarily be a competition for talent.” Therefore, Sheba Medical Center places great emphasis on cultivating and retaining talent.

Sheba Medical Center relies onTel Aviv University, supplying the hospital with outstanding talent; many of the hospital’s physicians are members of Tel Aviv University’s Faculty of Medicine. In addition, Sheba annually selects six to seven young academic elites and signs them to 10-year employment contracts. They receive a total funding package of $70,000, which supports both advanced study at the world’s leading universities and research institutions and participation in team-based training programs to develop management capabilities.

Before discussing Sheba’s internal mechanisms for medical innovation and translation, we must also note the national government’s efforts to foster an environment conducive to medical innovation."Green Environment". It is reported that the Israeli government's annual healthcare expenditure accounts for approximately 8% of its total fiscal budget.

In addition to investing substantial financial resources, the government has also established the National Bureau of Science and Technology Innovation and promulgated“Angel Act”, implement"National Science and Technology Incubator Program"A series of measures have been implemented to promote the flourishing development of the healthcare industry, from which Sheba Medical Center has greatly benefited.

“Research-Clinical Practice-Teaching and Training”The incubation system has facilitated Sheba Medical Center’s transformation from weakness to strength. However, to achieve a leap forward in medical innovation and translation, it is essential to rely on the wings that drive the commercial value of medical innovation—namely, the implementation of digital health strategic policies and the ARC Partner Innovation Program.

First, the left wing is a digital health strategic policy that serves as an "information repository."Leveraging its robust innovation capabilities and advanced technological infrastructure, it is committed to enhancing healthcare services through communication technologies. The digital health strategy comprises five specific dimensions:

First, establish a national digital health strategy and build a top-level architecture at the national level to support the Ministry of Health in fulfilling its corresponding responsibilities. Establish a shared mechanism for the exchange of health and management information, thereby supporting and promoting online diagnosis and treatment, personalized medicine, continuous care, and health management decision-making.

Second, after years of data collection, resident health information has achieved interoperability, with electronic health records (EHRs) basically covering the entire population in China. Information is stored across various Health Maintenance Organizations (HMOs) and medical institutions. Access to the National Health Information Exchange (HIE) platform enables the sharing of diagnostic and treatment data.

From the first two dimensions, the digital health strategy has already basically met the standards of its “information repository.” A large amount of information is the first step in launching ARC innovation projects, namely, finding scientific research opportunities within clinical practice.

Third, all medical services are fully computer-networked, achieving full informatization of the entire process from acquiring outpatient information to appointment scheduling, consultation, prescription, and referral.

Fourth, prioritize strengthening information security safeguards and resident privacy protection, and enhance the development of digital health regulations.

Fifth, establish a professional organizational system for cross-departmental coordination, while emphasizing the role of entrepreneurs and technology companies by launching a “Challenge Bidding Program,” under which the Ministry of Health will fund and promote the implementation of the winning digital solutions.

Secondly, the right wing is to build a bridge between hospitals and the market.ARC Partner Innovation Project(Accelerate Innovation to Redesign Healthcare and Collaborate with Partners), Sheba Medical Center has joined this innovation initiative alongside many other hospitals in Israel and around the world, primarilyBy regularly meeting with hospital medical teams to gather physicians’ insights and needs and to exchange updates on the latest projects and outcomes, we aim to foster collaboration among hospitals, startups, and large corporations in information sharing and other areas.

To turn ideas into reality, the center issues annually valued at$50,000grants to support innovative projects. Any department within the hospital may apply for funding, provided they propose innovative approaches to address specific challenges and contribute to improving care and treatment.

As projects mature in the laboratory and transition back to clinical settings, the center also provides proof-of-concept validation for partners’ technologies, integrating their innovative solutions into hospital and outpatient medical practice.

This process involves collaborating with the medical department to design pilot trials and oversee their implementation. If the pilot trials are successful, achieve the initially set objectives, and demonstrate value to the hospital, part of the agreement reached between the hospital and the startup is that the hospital is granted free use of their solution for the first two to three years.

In addition to the use of technology, startups are also required to cover the costs of pilot programs, and hospitals demand a small royalty fee for products co-developed with them.

Take Ventor Technologies as an example. The company developed a novel heart valve that can be implanted via catheter-based procedures rather than through open-heart surgery at Sheba Medical Center. In 2009, Medtronic acquired the medical device manufacturer Ventor Technologies (transapical) for $325 million to obtain its transcatheter aortic valve replacement (TAVR) product, with approximately 10% of the proceeds allocated to Sheba Medical Center.

In addition to its close ties with the company, ARC is also playing an active role in a project with the Ministry of Health and the Ministry of Finance, which aims to design a more proactive regulatory infrastructure for digital health companies. This is also one of the missions planned by the Israel Digital Health Association.

In terms of fundraising, the ARC Partners Innovation Project has significantly driven the commercialization of Sheba’s innovations.In 2021, six companies at the ARC Innovation Center raised over $110 million.. Startups related to Sheba have raised over the past decadeOver $1 billion.

Overall, Sheba’s position at the forefront of medical innovation and translation is primarily attributable to its “clinical–research–education and training” ecosystem model, which effectively integrates healthcare services, medical innovation, and talent development. Furthermore, this success is bolstered by digital health strategic policies and the ARC Partner Innovation Program, which transform clinical case data into innovative concepts and projects, thereby facilitating their market entry.